Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast

Comprehensive molecular portraits of human breast tumours

Nature · 2012 · 12.4K citations · Full text

Medicine, Molecular Biology, Oncology +14

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text

Life Sciences, Immunology, Oncology +17

The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα

Feng Li, Guogen Mao, Dan Tong et al. · Cell · 2013 · 603 citations · Full text

Life Sciences, Genetics, Molecular Biology +10

Refinement of breast cancer classification by molecular characterization of histological special types

Britta Weigelt, HM Horlings, Bas Kreike et al. · The Journal of Pathology · 2008 · 558 citations

Medicine, Oncology, Pathology +16

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer et al. · The Lancet Oncology · 2016 · 553 citations · Full text

Medicine, Oncology, Pharmacology +15